Exact Mass: 335.1288

Exact Mass Matches: 335.1288

Found 500 metabolites which its exact mass value is equals to given mass value 335.1288, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Senecionine

(1,6)Dioxacyclododecino(2,3,4-gh)pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-, (3Z,5R,6R,14aR,14bR)-

C18H25NO5 (335.1733)


Senecionine is a pyrrolizidine alkaloid isolated from the plant species of the genus Senecio. It has a role as a plant metabolite. It is a lactone, a pyrrolizidine alkaloid and a tertiary alcohol. It is functionally related to a senecionan. It is a conjugate base of a senecionine(1+). Senecionine is a natural product found in Dorobaea pimpinellifolia, Crotalaria micans, and other organisms with data available. Senecionine is an organic compound with the chemical formula C18H25NO5. It is classified as a pyrrolizidine alkaloid. See also: Petasites hybridus root (part of); Tussilago farfara flower (part of); Tussilago farfara leaf (part of). A pyrrolizidine alkaloid isolated from the plant species of the genus Senecio. D000970 - Antineoplastic Agents Annotation level-1 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2251 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 122 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 102 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 142 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 152 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 162 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 172 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 132 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 112 [Raw Data] CB082a_Senecionine_pos_40eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_10eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_30eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_20eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_50eV_CB000034.txt Senecionine (Senecionan-11,16-dione, 12-hydroxy-) is a pyrrolizidine alkaloid could be isolated from Senecio vulgaris. Senecionine decreases the activities of glutathione S-transferase, aminopyrine demethylase and arylhydrocarbon hydroxylase (AHH)[1][2][3]. Senecionine (Senecionan-11,16-dione, 12-hydroxy-) is a pyrrolizidine alkaloid could be isolated from Senecio vulgaris. Senecionine decreases the activities of glutathione S-transferase, aminopyrine demethylase and arylhydrocarbon hydroxylase (AHH)[1][2][3].

   

trifluralin

alpha,alpha,alpha-Trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine

C13H16F3N3O4 (335.1093)


D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 123 D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   
   

N-acetylglucosaminylasparagine

(2S)-2-amino-3-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl}propanoic acid

C12H21N3O8 (335.1329)


Aspartylglycosamine, also known as n4-(beta-N-acetyl-D-glucosaminyl)-L-asparagine or 1-beta-aspartyl-N-acetyl-D-glucosaminylamine, is a member of the class of compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Aspartylglycosamine is soluble (in water) and a moderately acidic compound (based on its pKa). Aspartylglycosamine can be found primarily in urine, as well as in human spleen tissue. Within the cell, aspartylglycosamine is primarily located in the cytoplasm. Moreover, aspartylglycosamine is found to be associated with aspartylglucosaminuria, which is an inborn error of metabolism. Large amount of aspartylglycosamine appears in patients with aspartylglycosaminuria corresponding to decreased activity of aspartylglycosamine amido hydrolase. Large amount of aspartylglycosamine appears in patients with aspartylglycosaminuria, which is a metabolic disorder associated with decreased activity of aspartylglycosamine amido hydrolase. [HMDB]

   

isopentenyl adenosine

(2R,3S,4R,5R)-2-(hydroxymethyl)-5-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxolane-3,4-diol

C15H21N5O4 (335.1593)


Riboprine, also known as isopentenyladenosine or ipa, is a member of the class of compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Riboprine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Riboprine can be found in a number of food items such as peppermint, chinese mustard, custard apple, and green bean, which makes riboprine a potential biomarker for the consumption of these food products. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins Acquisition and generation of the data is financially supported in part by CREST/JST. Same as: D05726 N6-Isopentenyladenosine (Riboprine), an RNA modification found in cytokinins, which regulate plant growth/differentiation, and a subset of tRNAs, where it improves the efficiency and accuracy of translation. N6-Isopentenyladenosine, an end product of the mevalonate pathway, is an autophagy inhibitor with an interesting anti-melanoma activity[1][2][3].

   

Senecivernine

21-Norsenecionan-11,16-dione, 12-hydroxy-14-methyl-, (12zeta,13zeta)-

C18H25NO5 (335.1733)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2276

   

Naratriptan

1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride

C17H25N3O2S (335.1667)


Naratriptan is only found in individuals that have used or taken this drug. It is a triptan drug used for the treatment of migraine headaches. It is a selective 5-hydroxytryptamine1 receptor subtype agonist.Three distinct pharmacological actions have been implicated in the antimigraine effect of the triptans: (1) stimulation of presynaptic 5-HT1D receptors, which serves to inhibit both dural vasodilation and inflammation; (2) direct inhibition of trigeminal nuclei cell excitability via 5-HT1B/1D receptor agonism in the brainstem and (3) vasoconstriction of meningeal, dural, cerebral or pial vessels as a result of vascular 5-HT1B receptor agonism. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

Triangularine

6-Angelyl-9-sarracinylretronecine

C18H25NO5 (335.1733)


   

(+)-Validoxylamine-A

(1S,2S,3R,6S)-4-(hydroxymethyl)-6-[[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino]cyclohex-4-ene-1,2,3-triol

C14H25NO8 (335.158)


An amino cyclitol that is (1R,2S,3S,4S,6R)-4-amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol in which one of the hydrogens attached to the nitrogen is replaced by a (1R,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl group. Validoxylamine A is an amino cyclitol that is (1R,2S,3S,4S,6R)-4-amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol in which one of the hydrogens attached to the nitrogen is replaced by a (1R,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl group. It has a role as an EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor, a bacterial metabolite, an antibiotic insecticide and an animal metabolite. It is an amino cyclitol and a secondary amino compound. It is functionally related to a validamine. It is a conjugate base of a validoxylamine A(1+). Validoxylamine A is a natural product found in Apis ceran

   

Mitomycin B

(1aS)-6-Methoxy-8aalpha-hydroxy-5-methyl-8alpha-[(carbamoyloxy)methyl]-1,1aalpha,2,8,8a,8balpha-hexahydroazirino[2,3:3,4]pyrrolo[1,2-a]indole-4,7-dione

C15H17N3O6 (335.1117)


   

7-demethylmitomycin A

(4-hydroxy-8a-methoxy-5-methyl-6,7-dioxo-1,1a,2,6,7,8,8a,8b-octahydroazireno[2,3:3,4]pyrrolo[1,2-a]indol-8-yl)methyl carbamate

C15H17N3O6 (335.1117)


A member of the family of mitomycins that is mitomycin A in which the methoxy group on the quinone ring is replaced by a hydroxy group.

   

gamma-Glutamyl-S-methylcysteinyl-beta-alanine

2-Amino-4-({1-[(2-carboxyethyl)-C-hydroxycarbonimidoyl]-2-(methylsulphanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C12H21N3O6S (335.1151)


gamma-Glutamyl-S-methylcysteinyl-beta-alanine is found in pulses. gamma-Glutamyl-S-methylcysteinyl-beta-alanine is a constituent of the seeds of the mung bean (Vigna radiata). Constituent of the seeds of the mung bean (Vigna radiata). gamma-Glutamyl-S-methylcysteinyl-beta-alanine is found in pulses.

   

Almotriptan

dimethyl(2-{5-[(pyrrolidine-1-sulfonyl)methyl]-1H-indol-3-yl}ethyl)amine

C17H25N3O2S (335.1667)


Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and stopping the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Almotriptan does not prevent migraine attacks. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Almotriptan is a selective agonist of 5-HT 1B/1D Receptor. Almotriptan can used in study of migraine attacks[1].

   

Tryptophyl-Methionine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-4-(methylsulphanyl)butanoic acid

C16H21N3O3S (335.1304)


Tryptophyl-Methionine is a dipeptide composed of tryptophan and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Methionyl-Tryptophan

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3S (335.1304)


Methionyl-Tryptophan is a dipeptide composed of methionine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Integerrimine

4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H25NO5 (335.1733)


   

N6-Cyclopentyladenosine

2-[6-(cyclopentylamino)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O4 (335.1593)


   

25C-NBOMe

2-(4-Chloro-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine

C18H22ClNO3 (335.1288)


   

2-Amino-5-[[1-(carboxymethylamino)-3-ethylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

2-Amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-(ethylsulphanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C12H21N3O6S (335.1151)


   

Acarviosin

6-[(4,5-dihydroxy-6-methoxy-2-methyloxan-3-yl)amino]-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol

C14H25NO8 (335.158)


   

Alkaloid A

{1-[(2-methylbut-2-enoyl)oxy]-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl}methyl 2-(hydroxymethyl)but-2-enoic acid

C18H25NO5 (335.1733)


   

benfluralin

N-Butyl-N-ethyl-alpha,alpha,alpha-trifluoro-2,6-dinitro-p-toluidine

C13H16F3N3O4 (335.1093)


   

3-(Phosphonomethyl)-5-phenyl-D-phenylalanine

(+)-alpha-Amino-3-(5-phosphonomethyl-[1.1-biphenyl]-3-yl) propanoic acid

C16H18NO5P (335.0923)


   

Cloquintocet-mexyl

1-Methylhexyl 2-[(5-chloro-8-quinolinyl)oxy]acetic acid

C18H22ClNO3 (335.1288)


   

Dansylcadaverine

N-(5-aminopentyl)-5-(dimethylamino)naphthalene-1-sulfonamide

C17H25N3O2S (335.1667)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   

Diethylenetriaminetetraacetic acid

2-{[2-({2-[bis(carboxymethyl)amino]ethyl}amino)ethyl](carboxymethyl)amino}acetic acid

C12H21N3O8 (335.1329)


   

N-(N-L-gamma-Glutamyl-L-cysteinyl)glycine monoethyl ester

2-Amino-4-({1-[(2-ethoxy-2-oxoethyl)-C-hydroxycarbonimidoyl]-2-sulphanylethyl}-C-hydroxycarbonimidoyl)butanoic acid

C12H21N3O6S (335.1151)


   

Hippuryl-L-arginine

5-[(diaminomethylidene)amino]-2-[2-(phenylformamido)acetamido]pentanoic acid

C15H21N5O4 (335.1593)


   

1-(4,5-Dimethylthiazol-2-yl)-3,5-diphenylformazan

N-[(4,5-dimethyl-1,3-thiazol-2-yl)imino]-N-(phenylamino)benzenecarboximidamide

C18H17N5S (335.1205)


   

Pirifibrate

(6-(Hydroxymethyl)-2-pyridyl)methyl-2-(4-chlorophenoxy)-2-methyl-propionate hydrochloride

C17H18ClNO4 (335.0924)


   

Ramixotidine

N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulphanyl]ethyl}-1-oxo-1-pyridine-3-carboximidic acid

C16H21N3O3S (335.1304)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist

   

Riboprine

2-(hydroxymethyl)-5-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxolane-3,4-diol

C15H21N5O4 (335.1593)


   

2-(4-(Benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine

2-(5-Benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride

C20H21N3O2 (335.1634)


   

3-[(2-Aminoethylamino)methyl]-3-[bis(carboxymethyl)amino]pentanedioic acid

3-{[(2-aminoethyl)amino]methyl}-3-[bis(carboxymethyl)amino]pentanedioic acid

C12H21N3O8 (335.1329)


   

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,3-dihydro-1H-tetrazole

2-(4,5-dimethyl-1,3-thiazol-2-yl)-3,5-diphenyl-2,3-dihydro-1H-1,2,3,4-tetrazole

C18H17N5S (335.1205)


   

Spiromustine

3-{2-[bis(2-chloroethyl)amino]ethyl}-1,3-diazaspiro[4.5]decane-2,4-dione

C14H23Cl2N3O2 (335.1167)


   

Tubastatin A

N-Hydroxy-4-[(2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl)methyl]benzamide

C20H21N3O2 (335.1634)


   

N-6-Isopent-2-enyl-adenosine

(2S,3R,4S,5S)-2-(hydroxymethyl)-5-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxolane-3,4-diol

C15H21N5O4 (335.1593)


N-6-isopent-2-enyl-adenosine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). N-6-isopent-2-enyl-adenosine can be found in wild celery, which makes N-6-isopent-2-enyl-adenosine a potential biomarker for the consumption of this food product.

   

Retroisosenine

Retroisosenine

C18H25NO5 (335.1733)


   
   

7,8-Dimethoxymyrtopsine

(+)-7,8-Dimethoxymyrtopsine

C17H21NO6 (335.1369)


   

Pyrrolo[2,1-b]quinazolin-9(1H)-one, 3-[o-(dimethylamino)phenyl]-2,3-dihydro-5-methoxy-

Pyrrolo[2,1-b]quinazolin-9(1H)-one, 3-[o-(dimethylamino)phenyl]-2,3-dihydro-5-methoxy-

C20H21N3O2 (335.1634)


   
   

Eremofortin E

Eremofortin E

C17H21NO6 (335.1369)


   
   
   
   
   
   

Rigidiusculamide D

Rigidiusculamide D

C18H25NO5 (335.1733)


   

Hydroxylunidine

Hydroxylunidine

C17H21NO6 (335.1369)


   

Cloquintocet-mexyl

Cloquintocet-mexyl

C18H22ClNO3 (335.1288)


CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10219; ORIGINAL_PRECURSOR_SCAN_NO 10218 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10248; ORIGINAL_PRECURSOR_SCAN_NO 10246 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10275; ORIGINAL_PRECURSOR_SCAN_NO 10273 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10288; ORIGINAL_PRECURSOR_SCAN_NO 10286 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10259; ORIGINAL_PRECURSOR_SCAN_NO 10258 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10304; ORIGINAL_PRECURSOR_SCAN_NO 10302

   

Fenamiphos sulfone

Fenamiphos sulfone

C13H22NO5PS (335.0956)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3703

   
   

N-[4-(Cyanomethyl)phenyl]-N-[4-(trifluoromethoxy)phenyl]urea

N-[4-(Cyanomethyl)phenyl]-N-[4-(trifluoromethoxy)phenyl]urea

C16H12F3N3O2 (335.0882)


   

2-Amino-3-({4-[4-(tert-butyl)-1,3-thiazol-2-yl]benzylidene}amino)but-2-enedinitrile

2-Amino-3-({4-[4-(tert-butyl)-1,3-thiazol-2-yl]benzylidene}amino)but-2-enedinitrile

C18H17N5S (335.1205)


   
   

5(6)-1(2H)-Phthalazinonyl-4(1H)-benzimidazole-2-carbamate methyl ester

5(6)-1(2H)-Phthalazinonyl-4(1H)-benzimidazole-2-carbamate methyl ester

C17H13N5O3 (335.1018)


   

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-thienyl)-, diethyl ester

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-thienyl)-, diethyl ester

C17H21NO4S (335.1191)


   
   
   
   
   
   
   

Neoascorbigen

Neoascorbigen

C16H17NO7 (335.1005)


   
   

3-Deoxy-3-methylaminoxylose-1,2-O-Isopropylidene, N-Ac, 5-benzyl

3-Deoxy-3-methylaminoxylose-1,2-O-Isopropylidene, N-Ac, 5-benzyl

C18H25NO5 (335.1733)


   
   

hydroxymethylmycophenolic acid amide

hydroxymethylmycophenolic acid amide

C17H21NO6 (335.1369)


   

7-Senecioyl-9-sarracinoyl retronecine|7-senecioyl-9-sarracinylretronecine

7-Senecioyl-9-sarracinoyl retronecine|7-senecioyl-9-sarracinylretronecine

C18H25NO5 (335.1733)


   
   

Araliopsinine

Araliopsinine

C17H21NO6 (335.1369)


   

Perforine

Perforine

C18H25NO5 (335.1733)


Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids; Origin: Plant

   
   

convolinine|N-hydroxyethylconvolvine

convolinine|N-hydroxyethylconvolvine

C18H25NO5 (335.1733)


   
   

Oprea1_408571

Oprea1_408571

C18H25NO5 (335.1733)


   
   

2,3-O-Isopropylidene-N-Dimethyladenosine

2,3-O-Isopropylidene-N-Dimethyladenosine

C15H21N5O4 (335.1593)


   

2-C-(4-methoxyindol-3-ylmethyl)-beta-L-xylo-3-hexulofuranosonic acid gamma-lactone|4-methoxyascorbigen

2-C-(4-methoxyindol-3-ylmethyl)-beta-L-xylo-3-hexulofuranosonic acid gamma-lactone|4-methoxyascorbigen

C16H17NO7 (335.1005)


   

3-[[2-Carboxy-2-(acetylamino)ethyl]thio]-4-hydroxynonanoic acid

3-[[2-Carboxy-2-(acetylamino)ethyl]thio]-4-hydroxynonanoic acid

C14H25NO6S (335.1403)


   

Zeatin 2-deoxyribofuranoside

Zeatin 2-deoxyribofuranoside

C15H21N5O4 (335.1593)


   

7-methoxycrinamabine

7-methoxycrinamabine

C17H21NO6 (335.1369)


   

2-acetamido-3-(3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoylthio)propanoic acid|JBIR-69

2-acetamido-3-(3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoylthio)propanoic acid|JBIR-69

C13H21NO7S (335.1039)


   
   

Dictyoterphenyl A

Dictyoterphenyl A

C20H17NO4 (335.1158)


   

3-Phenyl-5-(3-methyl-2-butenyl)-6-methoxy-8-hydroxyisoquinoline-1(2H)-one

3-Phenyl-5-(3-methyl-2-butenyl)-6-methoxy-8-hydroxyisoquinoline-1(2H)-one

C21H21NO3 (335.1521)


   

Cyclopiazonic acid imine

Cyclopiazonic acid imine

C20H21N3O2 (335.1634)


   
   

O1-(6-amino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Amino-[2]naphthyl)-beta-D-glucopyranuronsaeure

O1-(6-amino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Amino-[2]naphthyl)-beta-D-glucopyranuronsaeure

C16H17NO7 (335.1005)


   

11-Oxotetrodotoxin

11-Oxotetrodotoxin

C11H17N3O9 (335.0965)


   
   
   

7-((S)-2,3-Dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]chinolin-8-on|7-((S)-2,3-dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Hydroxylunidin|Hydroxylunidine|Isoorixin|isoorixine

7-((S)-2,3-Dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]chinolin-8-on|7-((S)-2,3-dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Hydroxylunidin|Hydroxylunidine|Isoorixin|isoorixine

C17H21NO6 (335.1369)


   

2-Deoxyribosylzeatin|2-Deoxyzeatin 9-beta-D-ribofuranoside|2-deoxyzeatin riboside|6-(4-hydroxy-3-methylbut-trans-2-enylamino)-9-beta-2-deoxy-D-ribofuranosylpurine|9-(2-deoxy-beta-D-ribofuranosyl)-trans-zeatin|cytokinin

2-Deoxyribosylzeatin|2-Deoxyzeatin 9-beta-D-ribofuranoside|2-deoxyzeatin riboside|6-(4-hydroxy-3-methylbut-trans-2-enylamino)-9-beta-2-deoxy-D-ribofuranosylpurine|9-(2-deoxy-beta-D-ribofuranosyl)-trans-zeatin|cytokinin

C15H21N5O4 (335.1593)


   

3alpha-hydroxy-6beta-(3-hydroxy-2-methyl-3-phenylpropionyloxy)-7beta-hydroxytropane

3alpha-hydroxy-6beta-(3-hydroxy-2-methyl-3-phenylpropionyloxy)-7beta-hydroxytropane

C18H25NO5 (335.1733)


   
   
   
   
   
   
   
   
   
   
   

Tubastatin A

N-hydroxy-4-((2H-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl)methyl)benzamide

C20H21N3O2 (335.1634)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Dehydroapocavidine

Dehydroapocavidine

C20H17NO4 (335.1158)


   

Squalidin

(1,6)DIOXACYCLODODECINO(2,3,4-GH)PYRROLIZINE-2,7-DIONE, 3-ETHYLIDENE-3,4,5,6,9,11,13,14,14A,14B-DECAHYDRO-6-HYDROXY-5,6-DIMETHYL-, (3E,5R,6R,14AR,14BR)-

C18H25NO5 (335.1733)


Integerrimine is a macrolide. Integerrimine is a natural product found in Crotalaria micans, Tussilago farfara, and other organisms with data available. See also: Petasites hybridus root (part of). D000970 - Antineoplastic Agents

   

isopentenyl-Adenosine-[d6]

isopentenyl-Adenosine-[d6]

C15H21N5O4 (335.1593)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Isopentenyl-Adenosine

Isopentenyl-Adenosine

C15H21N5O4 (335.1593)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Isopentenyladenosine

N6-Isopentenyladenosine

C15H21N5O4 (335.1593)


N6-Isopentenyladenosine (Riboprine), an RNA modification found in cytokinins, which regulate plant growth/differentiation, and a subset of tRNAs, where it improves the efficiency and accuracy of translation. N6-Isopentenyladenosine, an end product of the mevalonate pathway, is an autophagy inhibitor with an interesting anti-melanoma activity[1][2][3].

   

(E)-methyl 11-(5-carbamoyl-4-oxo-4H-pyran-2-yl)undec-10-enoate_120105

(E)-methyl 11-(5-carbamoyl-4-oxo-4H-pyran-2-yl)undec-10-enoate_120105

C18H25NO5 (335.1733)


   

N6-Isopentenyladenosine

6-(gamma,gamma-Dimethylallylamino)purine riboside

C15H21N5O4 (335.1593)


N6-Isopentenyladenosine (Riboprine), an RNA modification found in cytokinins, which regulate plant growth/differentiation, and a subset of tRNAs, where it improves the efficiency and accuracy of translation. N6-Isopentenyladenosine, an end product of the mevalonate pathway, is an autophagy inhibitor with an interesting anti-melanoma activity[1][2][3].

   
   

Riboprine

Isopentenyladenine riboside

C15H21N5O4 (335.1593)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins Same as: D05726 CONFIDENCE standard compound; INTERNAL_ID 306 N6-Isopentenyladenosine (Riboprine), an RNA modification found in cytokinins, which regulate plant growth/differentiation, and a subset of tRNAs, where it improves the efficiency and accuracy of translation. N6-Isopentenyladenosine, an end product of the mevalonate pathway, is an autophagy inhibitor with an interesting anti-melanoma activity[1][2][3].

   

3,N4-4-Oxo-2-hexenal-5-methyl-deoxycytidine

3,N4-4-Oxo-2-hexenal-5-methyl-deoxycytidine

C16H21N3O5 (335.1481)


   

Duguesuramine

Duguesuramine

C20H17NO4 (335.1158)


   
   
   

Desethylene-N-acetylnorfloxacin

Desethylene-N-acetylnorfloxacin

C16H18FN3O4 (335.1281)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Almotriptan

Almotriptan

C17H25N3O2S (335.1667)


N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Almotriptan is a selective agonist of 5-HT 1B/1D Receptor. Almotriptan can used in study of migraine attacks[1].

   

Aspartylglycosamine

Aspartylglycosamine

C12H21N3O8 (335.1329)


   

Met-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C16H21N3O3S (335.1304)


A dipeptide formed from L-methionine and L-tryptophan residues.

   

TRP-Met

2-[2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3S (335.1304)


   

S-Methylhomoglutathione

2-amino-4-({1-[(2-carboxyethyl)carbamoyl]-2-(methylsulfanyl)ethyl}carbamoyl)butanoic acid

C12H21N3O6S (335.1151)


   

CEHC glycine

N-(5-[(2R)-6-Hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl]-propanoyl)-glycine

C18H25NO5 (335.1733)


   

[(3R)-1-(3-fluorophenyl)pyrrolidin-3-yl] 4-methylbenzenesulfonate

[(3R)-1-(3-fluorophenyl)pyrrolidin-3-yl] 4-methylbenzenesulfonate

C17H18FNO3S (335.0991)


   

(3R,4S)-tert-Butyl 3-(1-ethoxyethoxy)-2-oxo-4-phenylazetidine-1-carboxylate

(3R,4S)-tert-Butyl 3-(1-ethoxyethoxy)-2-oxo-4-phenylazetidine-1-carboxylate

C18H25NO5 (335.1733)


   

mtt formazan

mtt formazan

C18H17N5S (335.1205)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013778 - Tetrazolium Salts D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D005562 - Formazans

   

Methionyltryptophan

Methionyltryptophan

C16H21N3O3S (335.1304)


   

C.I. Disperse Blue 106 press cake

C.I. Disperse Blue 106 press cake

C14H17N5O3S (335.1052)


   

2,3(1H)-ISOQUINOLINEDICARBOXYLIC ACID, 6-BORONO-3,4-DIHYDRO-, 2-(1,1-DIMETHYLETHYL) 3-METHYL ESTER

2,3(1H)-ISOQUINOLINEDICARBOXYLIC ACID, 6-BORONO-3,4-DIHYDRO-, 2-(1,1-DIMETHYLETHYL) 3-METHYL ESTER

C16H22BNO6 (335.154)


   

codeine hydrochloride

codeine hydrochloride

C18H22ClNO3 (335.1288)


   

(2S,3S,4S)-2-METHYL-2-(CARBOXYCYCLOPROPYL)GLYCINE

(2S,3S,4S)-2-METHYL-2-(CARBOXYCYCLOPROPYL)GLYCINE

C18H25NO5 (335.1733)


   

3-(Benzyloxy)-2-(2-(benzyloxy)ethoxy)pyridine

3-(Benzyloxy)-2-(2-(benzyloxy)ethoxy)pyridine

C21H21NO3 (335.1521)


   

2-N-BOC-8-METHOXY-2-METHYLAMINO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLICACID

2-N-BOC-8-METHOXY-2-METHYLAMINO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLICACID

C18H25NO5 (335.1733)


   

panadiplon

panadiplon

C18H17N5O2 (335.1382)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

N-Fmoc-piperidine-4-carbaldehyde

N-Fmoc-piperidine-4-carbaldehyde

C21H21NO3 (335.1521)


   

4-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]oxymethyl]benzoic acid

4-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]oxymethyl]benzoic acid

C18H25NO5 (335.1733)


   

6-AMINO-2-CHLORO-6,7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTEN-5-OLHYDROCHLORIDE

6-AMINO-2-CHLORO-6,7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTEN-5-OLHYDROCHLORIDE

C18H19ClFNO2 (335.1088)


   

Potassium tris(3,5-dimethyl-1-pyrazolyl)borate

Potassium tris(3,5-dimethyl-1-pyrazolyl)borate

C15H21BKN6 (335.1558)


   

SEMPERVIRINE, NITRATE, DIHYDRATE

SEMPERVIRINE, NITRATE, DIHYDRATE

C19H17N3O3 (335.127)


   
   

3-BENZYLOXY-1-TERT-BUTOXYCARBONYLAMINO-CYCLOPENTANECARBOXYLIC ACID

3-BENZYLOXY-1-TERT-BUTOXYCARBONYLAMINO-CYCLOPENTANECARBOXYLIC ACID

C18H25NO5 (335.1733)


   

Amlodipine besilate impurity G

Amlodipine besilate impurity G

C17H18ClNO4 (335.0924)


   

2-(4-[5-(TRIFLUOROMETHYL)-2-PYRIDYL]PIPERAZINO)BENZALDEHYDE

2-(4-[5-(TRIFLUOROMETHYL)-2-PYRIDYL]PIPERAZINO)BENZALDEHYDE

C17H16F3N3O (335.1245)


   

BIS-(4-NITROPHENYL)PHENYLAMINE

BIS-(4-NITROPHENYL)PHENYLAMINE

C18H13N3O4 (335.0906)


   

N6-Cyclopentyladenosine

N6-Cyclopentyladenosine

C15H21N5O4 (335.1593)


N6-Cyclopentyladenosine (CPA) is a selective Adenosine A1 receptor agonist, with Ki values of 2.3 nM, 790 nM and 43 nM for human A1, A2A and A3 receptors, respectively[1][2]. N6-Cyclopentyladenosine (CPA) is a selective Adenosine A1 receptor agonist, with Ki values of 2.3 nM, 790 nM and 43 nM for human A1, A2A and A3 receptors, respectively[1][2].

   

(3R,4S)-1-tert-butoxycarbonyl-3-(2-ethoxyethoxy)-4-phenyl-2-azetidione

(3R,4S)-1-tert-butoxycarbonyl-3-(2-ethoxyethoxy)-4-phenyl-2-azetidione

C18H25NO5 (335.1733)


   

Fmoc-L-propargylglycine

Fmoc-L-propargylglycine

C20H17NO4 (335.1158)


   

1-[[2,4,6-Tris(isopropyl)phenyl]sulfonyl]-1H-1,2,4-triazole

1-[[2,4,6-Tris(isopropyl)phenyl]sulfonyl]-1H-1,2,4-triazole

C17H25N3O2S (335.1667)


   

Fmoc-D-Pra-OH

Fmoc-D-Pra-OH

C20H17NO4 (335.1158)


   

Boc-(S)-3-Amino-4-(3-benzothienyl)-butyric acid

Boc-(S)-3-Amino-4-(3-benzothienyl)-butyric acid

C17H21NO4S (335.1191)


   

N-[(2S)-1-Phenyl-2-propanyl]-L-lysinamide dihydrochloride

N-[(2S)-1-Phenyl-2-propanyl]-L-lysinamide dihydrochloride

C15H27Cl2N3O (335.1531)


   

4,5-bis(phenylmethoxy)pyridine-2-carboxylic acid

4,5-bis(phenylmethoxy)pyridine-2-carboxylic acid

C20H17NO4 (335.1158)


   

Nylidrin hydrochloride

Nylidrin hydrochloride

C19H26ClNO2 (335.1652)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

SB505124

2-(4-(Benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine

C20H21N3O2 (335.1634)


   

4-Chloro-6-methoxy-7-(3-piperidin-1-yl-propoxy)-quinazoline

4-Chloro-6-methoxy-7-(3-piperidin-1-yl-propoxy)-quinazoline

C17H22ClN3O2 (335.14)


   

1-(1-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

1-(1-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

C23H17N3 (335.1422)


   

(4-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid

(4-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid

C15H18BNO5S (335.0999)


   

Spiromustine

Spiromustine

C14H23Cl2N3O2 (335.1167)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

tert-butyl N-tert-butoxycarbonyl-n-(7h-purin-6-yl)carbamate

tert-butyl N-tert-butoxycarbonyl-n-(7h-purin-6-yl)carbamate

C15H21N5O4 (335.1593)


   

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-1- piperidinecarboxylate

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-1- piperidinecarboxylate

C17H22ClN3O2 (335.14)


   

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-2-yl)-1- piperidinecarboxylate

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-2-yl)-1- piperidinecarboxylate

C17H22ClN3O2 (335.14)


   

N-tritylaniline

N-tritylaniline

C25H21N (335.1674)


   

N-[4-(TRIFLUOROMETHYL)BENZOYL]-L-METHIONINYL HYDRAZIDE

N-[4-(TRIFLUOROMETHYL)BENZOYL]-L-METHIONINYL HYDRAZIDE

C13H16F3N3O2S (335.0915)


   

1-Benzyl-4-(3-trifuoromethyl)phenyl-4-piperdinol

1-Benzyl-4-(3-trifuoromethyl)phenyl-4-piperdinol

C19H20F3NO (335.1497)


   

Isoetharine mesylate

4-[1-HYDROXY-2-([1-METHYLETHYL]AMINO)BUTYL]-1,2-BENZENEDIOL METHANESULFONATE

C14H25NO6S (335.1403)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Isoetharine (Isoetarine) mesylate is an orally active selective agonist of β-adrenergic receptors. Isoetharine mesylate is a catechol-like agent and catechol O-methyltransferase (COMT) mediates its methylation. Isoetharine mesylate can promote the production of cAMP which stimulates the relaxation of smooth muscle cells and can be used as an emphysema, bronchitis and bronchodilator[1][2].

   

tert-butyl 6-fluoro-4-oxospiro[3H-chromene-2,4-piperidine]-1-carboxylate

tert-butyl 6-fluoro-4-oxospiro[3H-chromene-2,4-piperidine]-1-carboxylate

C18H22FNO4 (335.1533)


   

2-(N-O-METHOXYPHENYL)CARBAMOYL-3-NAPHTHYL ACETATE

2-(N-O-METHOXYPHENYL)CARBAMOYL-3-NAPHTHYL ACETATE

C20H17NO4 (335.1158)


   

N-(3-Methyl-2-buten-1-yl)adenosine

N-(3-Methyl-2-buten-1-yl)adenosine

C15H21N5O4 (335.1593)


   

2C-C-NBOMe

N-(2-methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

C18H22ClNO3 (335.1288)


   
   

Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate

Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate

C21H18FNO2 (335.1321)


   

Boc-(R)-3-Amino-4-(3-benzothienyl)-butyric acid

Boc-(R)-3-Amino-4-(3-benzothienyl)-butyric acid

C17H21NO4S (335.1191)


   

Hippuryl-Arg-OH

Hippuryl-Arg-OH

C15H21N5O4 (335.1593)


   

{[(4-Ethyl-2,3-Dioxo-1-Piperazinyl) Carbonyl]Amino}-4-Hydroxy-Benzene Acetic Acid

{[(4-Ethyl-2,3-Dioxo-1-Piperazinyl) Carbonyl]Amino}-4-Hydroxy-Benzene Acetic Acid

C15H17N3O6 (335.1117)


   

2,12-DIFORMYL-DIBENZO[C,H]ACRIDINE

2,12-DIFORMYL-DIBENZO[C,H]ACRIDINE

C23H13NO2 (335.0946)


   

Pirifibrate

Pirifibrate

C17H18ClNO4 (335.0924)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

   

Benzeneacetic acid, a-hydroxy-a-phenyl-, 2-(dimethylamino)ethylester, hydrochloride (9CI)

Benzeneacetic acid, a-hydroxy-a-phenyl-, 2-(dimethylamino)ethylester, hydrochloride (9CI)

C18H22ClNO3 (335.1288)


   

Disperse Blue 106

2-[ethyl[3-methyl-4-[(5-nitrothiazol-2-yl)azo]phenyl]amino]ethanol

C14H17N5O3S (335.1052)


   

(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylamino]-2-(4-hydroxyphenyl)acetic acid

(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylamino]-2-(4-hydroxyphenyl)acetic acid

C15H17N3O6 (335.1117)


   

1-[3,4-Bis(benzyloxy)phenyl](2H3)ethanone

1-[3,4-Bis(benzyloxy)phenyl](2H3)ethanone

C22H17D3O3 (335.1601)


   

Fmoc-3,4-dehydro-L-proline

Fmoc-3,4-dehydro-L-proline

C20H17NO4 (335.1158)


   

Benzene,2-nitro-1,4-bis(phenylmethoxy)-

Benzene,2-nitro-1,4-bis(phenylmethoxy)-

C20H17NO4 (335.1158)


   

Levofloxacin Related Compound E

Levofloxacin Related Compound E

C16H18FN3O4 (335.1281)


   

4-[(2,2-Dimethyl-4,6-dioxo-[1,3]dioxan-5-ylidenemethyl)-amino]-2-methoxy-benzoic acid methyl ester

4-[(2,2-Dimethyl-4,6-dioxo-[1,3]dioxan-5-ylidenemethyl)-amino]-2-methoxy-benzoic acid methyl ester

C16H17NO7 (335.1005)


   

9,9-dimethyl-N-(naphthalen-2-yl)-9H-fluoren-2-amine

9,9-dimethyl-N-(naphthalen-2-yl)-9H-fluoren-2-amine

C25H21N (335.1674)


   

N-([1,1-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

N-([1,1-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

C24H17NO (335.131)


   

O-(Phenylmethyl)-L-threonine phenylmethyl ester hydrochloride

O-(Phenylmethyl)-L-threonine phenylmethyl ester hydrochloride

C18H22ClNO3 (335.1288)


   

2-(benzyloxycarbonyl)-3-(quinolin-4-yl)propanoic acid

2-(benzyloxycarbonyl)-3-(quinolin-4-yl)propanoic acid

C20H17NO4 (335.1158)


   

2-Dibenzofuranamine, N-[1,1-biphenyl]-4-yl

2-Dibenzofuranamine, N-[1,1-biphenyl]-4-yl

C24H17NO (335.131)


   

ethyl 2-piperazine-4-(3-fluoro)phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-(3-fluoro)phenyl thiazole-5-carboxylate

C16H18FN3O2S (335.1104)


   

DISPERSE BLUE 102

DISPERSE BLUE 102

C14H17N5O3S (335.1052)


   

Azido-PEG5-acid

Azido-PEG5-acid

C13H25N3O7 (335.1692)


   

L-Arginine β-naphthylamide hydrochloride

L-Arginine β-naphthylamide hydrochloride

C16H22ClN5O (335.1513)


   

ML-167

(5-(4-(((5-Methylfuran-2-yl)methyl)amino)quinazolin-6-yl)furan-2-yl)methanol

C19H17N3O3 (335.127)


   

(9H-FLUOREN-9-YL)METHYL (4-OXOCYCLOHEXYL)CARBAMATE

(9H-FLUOREN-9-YL)METHYL (4-OXOCYCLOHEXYL)CARBAMATE

C21H21NO3 (335.1521)


   

4-Tritylaniline

4-Tritylaniline

C25H21N (335.1674)


   

Glutathione reduced ethyl ester

Glutathione reduced ethyl ester

C12H21N3O6S (335.1151)


   

Boxidine

1-[2-[4-[4-(trifluoromethyl)phenyl]phenoxy]ethyl]pyrrolidine

C19H20F3NO (335.1497)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent

   

Despropylene Gatifloxacin

Despropylene Gatifloxacin

C16H18FN3O4 (335.1281)


   

(2-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid

(2-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid

C15H18BNO5S (335.0999)


   

3,5-bis-(Phenylmethoxy)-2-pyridinecarboxylic acid

3,5-bis-(Phenylmethoxy)-2-pyridinecarboxylic acid

C20H17NO4 (335.1158)


   

1-(9-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

1-(9-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

C23H17N3 (335.1422)


   

6-Hydroxy-5-undecyl-4,7-benzothiazoledione

6-Hydroxy-5-undecyl-4,7-benzothiazoledione

C18H25NO3S (335.1555)


   
   
   
   

S-Ethyl glutathione

S-Ethyl glutathione

C12H21N3O6S (335.1151)


D020011 - Protective Agents > D011837 - Radiation-Protective Agents

   
   
   

L-Methionine, L-tryptophyl-

L-Methionine, L-tryptophyl-

C16H21N3O3S (335.1304)


   

Coumarin, 7-hydroxy-4-phenyl-8-(piperidinomethyl)-

Coumarin, 7-hydroxy-4-phenyl-8-(piperidinomethyl)-

C21H21NO3 (335.1521)


   

4-Ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

4-Ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

C18H25NO5 (335.1733)


   
   

2-(1H-benzimidazol-2-ylthio)-1-(2,3-dimethyl-1-indolyl)ethanone

2-(1H-benzimidazol-2-ylthio)-1-(2,3-dimethyl-1-indolyl)ethanone

C19H17N3OS (335.1092)


   

N2-(4-fluorophenyl)-6-(3-methyl-2-benzofuranyl)-1,3,5-triazine-2,4-diamine

N2-(4-fluorophenyl)-6-(3-methyl-2-benzofuranyl)-1,3,5-triazine-2,4-diamine

C18H14FN5O (335.1182)


   

5-[1-[(4-Fluorophenyl)methyl]-3-pyrazolyl]-2-phenylthiazole

5-[1-[(4-Fluorophenyl)methyl]-3-pyrazolyl]-2-phenylthiazole

C19H14FN3S (335.0892)


   

N-[1-methyl-3-(trifluoromethyl)-5-thieno[2,3-c]pyrazolyl]carbamic acid 2,2-dimethylpropyl ester

N-[1-methyl-3-(trifluoromethyl)-5-thieno[2,3-c]pyrazolyl]carbamic acid 2,2-dimethylpropyl ester

C13H16F3N3O2S (335.0915)


   

N-(5,5-dimethyl-7-oxo-4,6-dihydro-1,3-benzothiazol-2-yl)-2-(2,5-dioxo-1-pyrrolidinyl)acetamide

N-(5,5-dimethyl-7-oxo-4,6-dihydro-1,3-benzothiazol-2-yl)-2-(2,5-dioxo-1-pyrrolidinyl)acetamide

C15H17N3O4S (335.094)


   

3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine

3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine

C18H14ClN5 (335.0938)


   

6-Amino-4-[2-(4-methoxyphenyl)ethyl]-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

6-Amino-4-[2-(4-methoxyphenyl)ethyl]-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

C18H17N5O2 (335.1382)


   

6-Chloro-4-(cyclohexylsulfanyl)-3-propylquinolin-2(1H)-one

6-Chloro-4-(cyclohexylsulfanyl)-3-propylquinolin-2(1H)-one

C18H22ClNOS (335.1111)


   

3-{[(9-Cyano-9,10-dihydro-10-methylacridin-9-YL)carbonyl]amino}propanoic acid

3-{[(9-Cyano-9,10-dihydro-10-methylacridin-9-YL)carbonyl]amino}propanoic acid

C19H17N3O3 (335.127)


   

2-{5-[Amino(iminio)methyl]-1H-indol-2-YL}-6-(cyclopentyloxy)benzenolate

2-{5-[Amino(iminio)methyl]-1H-indol-2-YL}-6-(cyclopentyloxy)benzenolate

C20H21N3O2 (335.1634)


   

Tert-Butyl 4-(3-Thiophen-2-Yl-1,2,4-Oxadiazol-5-Yl)piperidine-1-Carboxylate

Tert-Butyl 4-(3-Thiophen-2-Yl-1,2,4-Oxadiazol-5-Yl)piperidine-1-Carboxylate

C16H21N3O3S (335.1304)


   

3-[4-(1-Formylpiperazin-4-yl)-benzylidenyl]-2-indolinone

3-[4-(1-Formylpiperazin-4-yl)-benzylidenyl]-2-indolinone

C20H21N3O2 (335.1634)


   

Bis(5-amidino-benzimidazolyl)methane

Bis(5-amidino-benzimidazolyl)methane

C17H19N8+3 (335.1733)


   

({[(3E)-2-Oxo-2,7-dihydro-2,3-biindol-3(7H)-ylidene]amino}oxy)acetic acid

({[(3E)-2-Oxo-2,7-dihydro-2,3-biindol-3(7H)-ylidene]amino}oxy)acetic acid

C18H13N3O4 (335.0906)


   
   

N-[1-(3-methylbenzyl)-1H-pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide

N-[1-(3-methylbenzyl)-1H-pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide

C19H17N3O3 (335.127)


   

3-[1-(4-Carbamimidoylphenyl)triazol-4-yl]-4-methoxybenzenecarboximidamide

3-[1-(4-Carbamimidoylphenyl)triazol-4-yl]-4-methoxybenzenecarboximidamide

C17H17N7O (335.1495)


   

4-[[3-(4-phenoxyphenyl)-1H-pyrazol-5-yl]methyl]morpholine

4-[[3-(4-phenoxyphenyl)-1H-pyrazol-5-yl]methyl]morpholine

C20H21N3O2 (335.1634)


   

N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine zwitterion

N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine zwitterion

C12H21N3O8 (335.1329)


Zwitterionic form of N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

(S)-malyl N-acetyl-alpha-D-glucosaminide(2-)

(S)-malyl N-acetyl-alpha-D-glucosaminide(2-)

C12H17NO10-2 (335.0852)


   

a Steroid sulfate

a Steroid sulfate

C18H23O4S- (335.1317)


   

Diaminobutyryl-citryl-ethanolamine

Diaminobutyryl-citryl-ethanolamine

C12H21N3O8 (335.1329)


   

7-demethylmitomycin B

7-demethylmitomycin B

C15H17N3O6 (335.1117)


A member of the family of mitomycins that is mitomycin B in which the methoxy group on the quinone ring is replaced by a hydroxy group.

   

(2R,3S,9R)-5-acetyl-8,8-dimethyl-6-oxo-7,16-diazapentacyclo[9.6.1.02,9.03,7.015,18]octadeca-1(17),4,11(18),12,14-pentaen-4-olate

(2R,3S,9R)-5-acetyl-8,8-dimethyl-6-oxo-7,16-diazapentacyclo[9.6.1.02,9.03,7.015,18]octadeca-1(17),4,11(18),12,14-pentaen-4-olate

C20H19N2O3- (335.1396)


   

(1R,4Z,6R,7R)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

(1R,4Z,6R,7R)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

C18H25NO5 (335.1733)


   

Illudacetalate

Illudacetalate

C18H23O6- (335.1495)


   

2-[2-[(3-Amino-3-carboxypropyl)amino]-2-oxoethyl]-4-(2-aminoethoxy)-2-hydroxy-4-oxobutanoic acid

2-[2-[(3-Amino-3-carboxypropyl)amino]-2-oxoethyl]-4-(2-aminoethoxy)-2-hydroxy-4-oxobutanoic acid

C12H21N3O8 (335.1329)


   

Pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl(1,6)dioxacyclododecino(2,3,4-gh)-

Pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl(1,6)dioxacyclododecino(2,3,4-gh)-

C18H25NO5 (335.1733)


D000970 - Antineoplastic Agents

   

Neo-triangularine

Neo-triangularine

C18H25NO5 (335.1733)


   

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,3-dihydro-1H-tetrazole

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,3-dihydro-1H-tetrazole

C18H17N5S (335.1205)


   

N-6-Isopent-2-enyl-adenosine

N-6-Isopent-2-enyl-adenosine

C15H21N5O4 (335.1593)


   

2-Amino-5-[[1-(carboxymethylamino)-3-ethylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

2-Amino-5-[[1-(carboxymethylamino)-3-ethylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C12H21N3O6S (335.1151)


   

BTCP hydrochloride

BTCP hydrochloride

C19H26ClNS (335.1474)


   

Pyridinopyrone C

Pyridinopyrone C

C21H21NO3 (335.1521)


A natural product found in Streptomyces species.

   

Pyridinopyrone B

Pyridinopyrone B

C21H21NO3 (335.1521)


A natural product found in Streptomyces species.

   

Thr-Thr-Asp

Thr-Thr-Asp

C12H21N3O8 (335.1329)


A tripeptide composed of two L-threonine units and L-aspartic acid joined by peptide linkages.

   

n(6)-Isopentenyladenosine

n(6)-Isopentenyladenosine

C15H21N5O4 (335.1593)


   

4-methyl-N-[(2-methylquinolin-4-yl)methyl]-3-nitrobenzamide

4-methyl-N-[(2-methylquinolin-4-yl)methyl]-3-nitrobenzamide

C19H17N3O3 (335.127)


   

4-[[6-methyl-2-(6-oxo-1-cyclohexa-2,4-dienylidene)-1H-pyrimidin-4-yl]amino]benzoic acid methyl ester

4-[[6-methyl-2-(6-oxo-1-cyclohexa-2,4-dienylidene)-1H-pyrimidin-4-yl]amino]benzoic acid methyl ester

C19H17N3O3 (335.127)


   

3-(2-fluorobenzyl)-5-(1H-indol-3-ylmethylene)-2,4-imidazolidinedione

3-(2-fluorobenzyl)-5-(1H-indol-3-ylmethylene)-2,4-imidazolidinedione

C19H14FN3O2 (335.107)


   

6-(3-furanyl)-N-methyl-N-[(3-methyl-2-thiophenyl)methyl]-4-quinazolinamine

6-(3-furanyl)-N-methyl-N-[(3-methyl-2-thiophenyl)methyl]-4-quinazolinamine

C19H17N3OS (335.1092)


   

5-[(3-Methylanilino)methylidene]-1-(2-methylphenyl)-1,3-diazinane-2,4,6-trione

5-[(3-Methylanilino)methylidene]-1-(2-methylphenyl)-1,3-diazinane-2,4,6-trione

C19H17N3O3 (335.127)


   

5-(2-hydroxy-3,5-dimethylphenyl)-N-(4-methylbenzyl)-1H-pyrazole-3-carboxamide

5-(2-hydroxy-3,5-dimethylphenyl)-N-(4-methylbenzyl)-1H-pyrazole-3-carboxamide

C20H21N3O2 (335.1634)


   

4-[[Dimethoxyphosphoryl(phenyl)methyl]amino]benzoic acid

4-[[Dimethoxyphosphoryl(phenyl)methyl]amino]benzoic acid

C16H18NO5P (335.0923)


   

2-[[anilino(oxo)methyl]amino]-N-(2-furanylmethyl)benzamide

2-[[anilino(oxo)methyl]amino]-N-(2-furanylmethyl)benzamide

C19H17N3O3 (335.127)


   

8-Methoxy-1-(4-methoxyphenyl)-3-methyl-2-oxidobenzofuro[3,2-c]pyridin-2-ium

8-Methoxy-1-(4-methoxyphenyl)-3-methyl-2-oxidobenzofuro[3,2-c]pyridin-2-ium

C20H17NO4 (335.1158)


   

l-Prolyl-glycyl-l-tyrosine

l-Prolyl-glycyl-l-tyrosine

C16H21N3O5 (335.1481)


   

4-[1-[(3-Methoxy-4-methylphenyl)methyl]-2-benzimidazolyl]-1,2,5-oxadiazol-3-amine

4-[1-[(3-Methoxy-4-methylphenyl)methyl]-2-benzimidazolyl]-1,2,5-oxadiazol-3-amine

C18H17N5O2 (335.1382)


   

1-[(4-Tert-butylphenyl)methyl]-4-(4-nitrophenyl)imidazole

1-[(4-Tert-butylphenyl)methyl]-4-(4-nitrophenyl)imidazole

C20H21N3O2 (335.1634)


   

3-methyl-N-[[(2-methyl-5-quinolinyl)amino]-sulfanylidenemethyl]benzamide

3-methyl-N-[[(2-methyl-5-quinolinyl)amino]-sulfanylidenemethyl]benzamide

C19H17N3OS (335.1092)


   

N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)-4-methoxybenzenesulfonamide

N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)-4-methoxybenzenesulfonamide

C17H21NO4S (335.1191)


   

N-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-propyl-2-pyridinecarboxamide

N-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-propyl-2-pyridinecarboxamide

C20H21N3O2 (335.1634)


   

ethyl 2-{[(E)-(4,4-dimethyl-2,6-dioxocyclohexyl)methylidene]amino}-5-methylthiophene-3-carboxylate

ethyl 2-{[(E)-(4,4-dimethyl-2,6-dioxocyclohexyl)methylidene]amino}-5-methylthiophene-3-carboxylate

C17H21NO4S (335.1191)


   

2-(2,4-dioxo-3-thiazolidinyl)-N-[4-(4-morpholinyl)phenyl]acetamide

2-(2,4-dioxo-3-thiazolidinyl)-N-[4-(4-morpholinyl)phenyl]acetamide

C15H17N3O4S (335.094)


   

2-[(6-methyl-1H-benzimidazol-2-yl)thio]-1-(2-methyl-1H-indol-3-yl)ethanone

2-[(6-methyl-1H-benzimidazol-2-yl)thio]-1-(2-methyl-1H-indol-3-yl)ethanone

C19H17N3OS (335.1092)


   

5-(4-Methoxyanilino)-2-[(3-methylphenoxy)methyl]-4-oxazolecarbonitrile

5-(4-Methoxyanilino)-2-[(3-methylphenoxy)methyl]-4-oxazolecarbonitrile

C19H17N3O3 (335.127)


   

2-(7-Oxo-7-phenylheptyl)isoindoline-1,3-dione

2-(7-Oxo-7-phenylheptyl)isoindoline-1,3-dione

C21H21NO3 (335.1521)


   

N-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-propan-2-yl-4-pyridinecarboxamide

N-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-propan-2-yl-4-pyridinecarboxamide

C20H21N3O2 (335.1634)


   

(2R)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

(2R)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

C18H22ClNO3 (335.1288)


   

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] furan-2-carboxylate

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] furan-2-carboxylate

C18H13N3O4 (335.0906)


   

(1Z)-1-[(6aR,11aS,11bR)-7,7-dimethyl-9,11-dioxo-2,6a,7,11,11a,11b-hexahydro-6H-pyrrolo[1,2:2,3]isoindolo[4,5,6-cd]indol-10(9H)-ylidene]ethanolate

(1Z)-1-[(6aR,11aS,11bR)-7,7-dimethyl-9,11-dioxo-2,6a,7,11,11a,11b-hexahydro-6H-pyrrolo[1,2:2,3]isoindolo[4,5,6-cd]indol-10(9H)-ylidene]ethanolate

C20H19N2O3- (335.1396)


   

5,7-dimethyl-3-[3-(trifluoromethyl)phenyl]azo-1H-pyrazolo[1,5-a]pyrimidin-2-one

5,7-dimethyl-3-[3-(trifluoromethyl)phenyl]azo-1H-pyrazolo[1,5-a]pyrimidin-2-one

C15H12F3N5O (335.0994)


   

N-[2-[(4,5-dimethyl-1,2,4-triazol-3-yl)thio]-1-oxoethyl]-4-methoxybenzohydrazide

N-[2-[(4,5-dimethyl-1,2,4-triazol-3-yl)thio]-1-oxoethyl]-4-methoxybenzohydrazide

C14H17N5O3S (335.1052)


   

N-[(1E)-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]-3-fluorobenzohydrazide

N-[(1E)-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]-3-fluorobenzohydrazide

C20H18FN3O (335.1434)


   

Met-Ala-Asp

Met-Ala-Asp

C12H21N3O6S (335.1151)


A tripeptide composed of L-methionine, L-alanine and L-aspartic acid joined in sequence by peptide linkages.

   
   
   
   
   
   
   

N-[(E)-(1-methylindol-3-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

N-[(E)-(1-methylindol-3-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

C19H17N3O3 (335.127)


   

(2S)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

(2S)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

C18H22ClNO3 (335.1288)


   

4-[4-[(2S,3S,4S)-2-cyano-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

4-[4-[(2S,3S,4S)-2-cyano-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

C20H21N3O2 (335.1634)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

3-(1H-indol-3-yl)-2-[[(Z)-3-pyridin-2-ylprop-2-enoyl]amino]propanoic acid

3-(1H-indol-3-yl)-2-[[(Z)-3-pyridin-2-ylprop-2-enoyl]amino]propanoic acid

C19H17N3O3 (335.127)


   

Ethyl (Z)-2-cyano-3-(2-piperidin-1-ylquinolin-3-yl)prop-2-enoate

Ethyl (Z)-2-cyano-3-(2-piperidin-1-ylquinolin-3-yl)prop-2-enoate

C20H21N3O2 (335.1634)


   

2-(1H-benzimidazol-2-yl)-4-(3,4-dimethoxyphenyl)-3-oxobutanenitrile

2-(1H-benzimidazol-2-yl)-4-(3,4-dimethoxyphenyl)-3-oxobutanenitrile

C19H17N3O3 (335.127)


   

4-[(Z)-[(2,6-dimethylquinolin-4-yl)hydrazinylidene]methyl]-2-ethoxyphenol

4-[(Z)-[(2,6-dimethylquinolin-4-yl)hydrazinylidene]methyl]-2-ethoxyphenol

C20H21N3O2 (335.1634)


   

[(4S,6S,7R)-11,13-dihydroxy-7-methoxy-12-methyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

[(4S,6S,7R)-11,13-dihydroxy-7-methoxy-12-methyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

C15H17N3O6 (335.1117)


   

[(4S,6S,7R)-7,11,13-trihydroxy-5,12-dimethyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

[(4S,6S,7R)-7,11,13-trihydroxy-5,12-dimethyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

C15H17N3O6 (335.1117)


   

(2S)-2-(4-ethyl-1-methyl-6-oxopyrimidin-2-yl)sulfanyl-N-(4-fluorophenyl)propanamide

(2S)-2-(4-ethyl-1-methyl-6-oxopyrimidin-2-yl)sulfanyl-N-(4-fluorophenyl)propanamide

C16H18FN3O2S (335.1104)


   
   

4-Benzoyl-2,6-diphenylpyridine

4-Benzoyl-2,6-diphenylpyridine

C24H17NO (335.131)


   

N-Acetylglycylphenylalanylglycine methyl ester

N-Acetylglycylphenylalanylglycine methyl ester

C16H21N3O5 (335.1481)


   

N-Acetyl-glycyl-phenylalanyl-glycine methylester

N-Acetyl-glycyl-phenylalanyl-glycine methylester

C16H21N3O5 (335.1481)


   

2-Benzyl-4-methyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

2-Benzyl-4-methyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

C19H17N3O3 (335.127)


   

naratriptan

naratriptan

C17H25N3O2S (335.1667)


N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

N-Acetylglucosaminylasparagine

N(4)-(beta-N-Acetyl-D-glucosaminyl)-L-asparagine

C12H21N3O8 (335.1329)


An N(4)-glycosyl-L-asparagine having (beta-N-acetyl-D-glucosaminyl as the glycosyl component.

   

(S)-malyl N-acetyl-alpha-D-glucosaminide(2-)

(S)-malyl N-acetyl-alpha-D-glucosaminide(2-)

C12H17NO10 (335.0852)


A carbohydrate acid derivative anion obtained by deprotonation of both carboxy groups of (S)-malyl N-acetyl-alpha-D-glucosaminide; major species at pH 7.3.

   

trifluralin

trifluralin

C13H16F3N3O4 (335.1093)


D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

Dansylcadaverine

Dansylcadaverine

C17H25N3O2S (335.1667)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   

tryptophylmethionine

tryptophylmethionine

C16H21N3O3S (335.1304)


   

2-[6-(Cyclopentylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[6-(Cyclopentylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O4 (335.1593)


   

gamma-Glutamyl-S-methylcysteinyl-beta-alanine

gamma-Glutamyl-S-methylcysteinyl-beta-alanine

C12H21N3O6S (335.1151)


   

alpha-cyclopiazonate

alpha-cyclopiazonate

C20H19N2O3 (335.1396)


An organic anion that is the conjugate base of alpha-cyclopiazonic acid; major species at pH 7.3.

   

N(6)-(delta(2)-Isopentenyl)adenosine

N(6)-(delta(2)-Isopentenyl)adenosine

C15H21N5O4 (335.1593)


A nucleoside analogue in which adenosine has been modified by substitution at the 6-amino nitrogen by a Delta(2)-isopentenyl group.

   

N-(2-Methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

N-(2-Methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

C18H22ClNO3 (335.1288)


   
   

N-(3-methylbut-3-en-1-yl)adenosine

N-(3-methylbut-3-en-1-yl)adenosine

C15H21N5O4 (335.1593)


   
   

AMPA receptor modulator-3

AMPA receptor modulator-3

C18H22FNO2S (335.1355)


AMPA receptor modulator-3 is an allosteric AMPA receptor modulator (EC50: 4.4 μM). AMPA receptor modulator-3 can be used in the research of mammalian nervous system, such as learning and memory[1][2].

   

Glutathione ethyl ester

Glutathione ethyl ester

C12H21N3O6S (335.1151)


Glutathione ethyl ester is a cell-permeable GSH donor and provides an efficient supply of GSH to the oocyte. Glutathione ethyl ester shows positive effect on the in vitro production of embryos by enhancement of the antioxidative defense[1].

   

LAS101057

LAS101057

C18H14FN5O (335.1182)


LAS101057 is a potent, selective, and orally efficacious A2B receptor antagonist.

   

Longdaysin

Longdaysin

C16H16F3N5 (335.1358)


Longdaysin is a inhibitor of the Wnt/β-catenin signaling pathway, which exerts antitumor effect through blocking CK1δ/ε-dependent Wnt signaling. Longdaysin inhibits CK1α, CK1δ, CDK7, and ERK2 with IC50s of? 5.6 μM, 8.8 μM, 29 μM, and 52 μM, respectively[1][2].

   

N-Formyl-Met-Ala-Ser

N-Formyl-Met-Ala-Ser

C12H21N3O6S (335.1151)


N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.

   

NL-1

NL-1

C18H25NO3S (335.1555)


NL-1 is a mitoNEET inhibitor with antileukemic effect. NL-1 inhibits REH and REH/Ara-C cells growth with IC50s of 47.35 μM and 56.26 μM, respectively. NL-1-mediated death in leukemic cells requires the activation of the autophagic pathway[1].

   

VU0364289

VU0364289

C20H21N3O2 (335.1634)


VU0364289 is a highly selective mGlu5 positive allosteric modulator (PAM) (binds to the MPEP (HY-14609A) site), with an EC50 of 1.6 μM. VU0364289 can reverse amphetamine-induced hyperlocomotion in a dose-dependent manner, which can be used for schizophrenia and other psychiatric research[1][2][3].

   

5-(1-aminoethylidene)-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraene-4,6-dione

5-(1-aminoethylidene)-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraene-4,6-dione

C20H21N3O2 (335.1634)


   

2-{2-[1-(dimethylamino)-2-phenylethyl]-1,3-oxazole-5-carbonyl}aniline

2-{2-[1-(dimethylamino)-2-phenylethyl]-1,3-oxazole-5-carbonyl}aniline

C20H21N3O2 (335.1634)


   

(2r,3s,5r)-5-(6-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

(2r,3s,5r)-5-(6-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C15H21N5O4 (335.1593)


   

(1r,4e,6s,7r,17s)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(1r,4e,6s,7r,17s)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H25NO5 (335.1733)


   

(1'r,2r,4s,4'r,7's)-4-methyl-4'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-11'-oxa-5'-azaspiro[oxolane-2,10'-tricyclo[5.3.1.0¹,⁵]undecan]-5-one

(1'r,2r,4s,4'r,7's)-4-methyl-4'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-11'-oxa-5'-azaspiro[oxolane-2,10'-tricyclo[5.3.1.0¹,⁵]undecan]-5-one

C18H25NO5 (335.1733)


   

5-{5-[(acetyloxy)methyl]-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl}-2-methyl-4-oxopent-2-enimidic acid

5-{5-[(acetyloxy)methyl]-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl}-2-methyl-4-oxopent-2-enimidic acid

C18H25NO5 (335.1733)


   

(2r)-2-[(2s)-6-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

(2r)-2-[(2s)-6-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

C16H17NO7 (335.1005)


   

n-({2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}methyl)ethanimidic acid

n-({2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}methyl)ethanimidic acid

C16H21N3O3S (335.1304)


   

2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C17H21NO6 (335.1369)


   

1-chloro-n-(2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl)methanecarbonimidoyl chloride

1-chloro-n-(2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl)methanecarbonimidoyl chloride

C16H24Cl3N (335.0974)


   

(1r,4e,7r,11s,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

(1r,4e,7r,11s,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

C18H25NO5 (335.1733)


   

n-{[(2r,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2r,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   

(4e)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(4e)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H25NO5 (335.1733)


   
   

3-[(3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoyl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

3-[(3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoyl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

C13H21NO7S (335.1039)


   

3α-(3',4',5'-trimethoxybenzoyloxy)tropane

NA

C18H25NO5 (335.1733)


{"Ingredient_id": "HBIN007914","Ingredient_name": "3\u03b1-(3',4',5'-trimethoxybenzoyloxy)tropane","Alias": "NA","Ingredient_formula": "C18H25NO5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21880","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

adhatodine

NA

C20H21N3O2 (335.1634)


{"Ingredient_id": "HBIN014711","Ingredient_name": "adhatodine","Alias": "NA","Ingredient_formula": "C20H21N3O2","Ingredient_Smile": "CNC1=C(C=C(C=C1)C2CCN3C2=NC4=CC=CC=C4C3)C(=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "627","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(7s,8s)-8-(3-hydroxy-3-methylbutyl)-4,8-dimethoxy-5h,6h,7h-furo[2,3-b]quinolin-7-ol

(7s,8s)-8-(3-hydroxy-3-methylbutyl)-4,8-dimethoxy-5h,6h,7h-furo[2,3-b]quinolin-7-ol

C18H25NO5 (335.1733)


   

8-(3-hydroxy-3-methylbutyl)-4,8-dimethoxy-5h,6h,7h-furo[2,3-b]quinolin-7-ol

8-(3-hydroxy-3-methylbutyl)-4,8-dimethoxy-5h,6h,7h-furo[2,3-b]quinolin-7-ol

C18H25NO5 (335.1733)


   

(2r,3r,4s,5s)-2-(hydroxymethyl)-5-{6-[(3-methylbut-2-en-1-yl)amino]purin-9-yl}oxolane-3,4-diol

(2r,3r,4s,5s)-2-(hydroxymethyl)-5-{6-[(3-methylbut-2-en-1-yl)amino]purin-9-yl}oxolane-3,4-diol

C15H21N5O4 (335.1593)


   

3-{4',6-dihydroxy-[1,1'-biphenyl]-3-yl}-4-methoxybenzenecarboximidic acid

3-{4',6-dihydroxy-[1,1'-biphenyl]-3-yl}-4-methoxybenzenecarboximidic acid

C20H17NO4 (335.1158)


   

[(7r,7as)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2e)-2-(hydroxymethyl)but-2-enoate

[(7r,7as)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2e)-2-(hydroxymethyl)but-2-enoate

C18H25NO5 (335.1733)


   

10-{[2-(4-hydroxyphenyl)ethyl]imino}-2,7-dimethyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,8-trien-11-one

10-{[2-(4-hydroxyphenyl)ethyl]imino}-2,7-dimethyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,8-trien-11-one

C20H21N3O2 (335.1634)


   

4-methoxy-3-methyl-6-[5-methyl-8-(pyridin-3-yl)octa-1,3,5,7-tetraen-1-yl]pyran-2-one

4-methoxy-3-methyl-6-[5-methyl-8-(pyridin-3-yl)octa-1,3,5,7-tetraen-1-yl]pyran-2-one

C21H21NO3 (335.1521)


   

2-amino-4-({1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-(methylsulfanyl)ethyl}-c-hydroxycarbonimidoyl)butanoic acid

2-amino-4-({1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-(methylsulfanyl)ethyl}-c-hydroxycarbonimidoyl)butanoic acid

C12H21N3O6S (335.1151)


   

(1as,2s,3r,3'r,3ar,5s,7br)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

(1as,2s,3r,3'r,3ar,5s,7br)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

C17H21NO6 (335.1369)


   

(2e)-5-[(6s)-5-[(acetyloxy)methyl]-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl]-2-methyl-4-oxopent-2-enimidic acid

(2e)-5-[(6s)-5-[(acetyloxy)methyl]-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl]-2-methyl-4-oxopent-2-enimidic acid

C18H25NO5 (335.1733)


   

16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),2,4(8),9,11,15,17,19-octaene

16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),2,4(8),9,11,15,17,19-octaene

C20H17NO4 (335.1158)


   

(2r)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

(2r)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

C17H21NO6 (335.1369)


   

6-ethylidene-5-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1h-pyrazin-2-one

6-ethylidene-5-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1h-pyrazin-2-one

C20H21N3O2 (335.1634)


   

methyl 2-(methylamino)-5-{1h,2h,3h,9h-pyrrolo[2,1-b]quinazolin-3-yl}benzoate

methyl 2-(methylamino)-5-{1h,2h,3h,9h-pyrrolo[2,1-b]quinazolin-3-yl}benzoate

C20H21N3O2 (335.1634)


   

1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

C17H21NO6 (335.1369)


   

3-[(2r,3s)-3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl]-2-methylprop-2-enoic acid

3-[(2r,3s)-3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl]-2-methylprop-2-enoic acid

C17H21NO6 (335.1369)


   

(2r)-3-{[(2s,3r)-3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-{[(2s,3r)-3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C13H21NO7S (335.1039)


   

methyl 2-{[(3s)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]amino}benzoate

methyl 2-{[(3s)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]amino}benzoate

C19H17N3O3 (335.127)


   

(2s)-2-{[(2s,3r)-2-{[(2s,3r)-2-amino-1,3-dihydroxybutylidene]amino}-1,3-dihydroxybutylidene]amino}butanedioic acid

(2s)-2-{[(2s,3r)-2-{[(2s,3r)-2-amino-1,3-dihydroxybutylidene]amino}-1,3-dihydroxybutylidene]amino}butanedioic acid

C12H21N3O8 (335.1329)


   

3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C17H21NO6 (335.1369)


   

(1r,13s,16s,17r)-9-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol

(1r,13s,16s,17r)-9-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol

C17H21NO6 (335.1369)


   

(2s,3s,5e,9r)-5-(1-aminoethylidene)-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraene-4,6-dione

(2s,3s,5e,9r)-5-(1-aminoethylidene)-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraene-4,6-dione

C20H21N3O2 (335.1634)


   

(2s)-2-amino-3-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]-c-hydroxycarbonimidoyl}propanoic acid

(2s)-2-amino-3-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]-c-hydroxycarbonimidoyl}propanoic acid

C12H21N3O8 (335.1329)


   

4-methoxy-3-methyl-6-[3-methyl-8-(pyridin-3-yl)octa-1,3,5,7-tetraen-1-yl]pyran-2-one

4-methoxy-3-methyl-6-[3-methyl-8-(pyridin-3-yl)octa-1,3,5,7-tetraen-1-yl]pyran-2-one

C21H21NO3 (335.1521)


   

7-(2,3-dihydroxy-3-methylbutyl)-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

7-(2,3-dihydroxy-3-methylbutyl)-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

C17H21NO6 (335.1369)


   

(2r,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

(2r,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C17H21NO6 (335.1369)


   

(3s,3as,6s,6ar)-3,3a,6-trihydroxy-3-[(1-methoxyindol-3-yl)methyl]-dihydro-5h-furo[3,2-b]furan-2-one

(3s,3as,6s,6ar)-3,3a,6-trihydroxy-3-[(1-methoxyindol-3-yl)methyl]-dihydro-5h-furo[3,2-b]furan-2-one

C16H17NO7 (335.1005)


   

1-chloro-n-[(6e)-2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl]methanecarbonimidoyl chloride

1-chloro-n-[(6e)-2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl]methanecarbonimidoyl chloride

C16H24Cl3N (335.0974)


   

(1ar,2r,3r,3's,3ar,5r,7bs)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

(1ar,2r,3r,3's,3ar,5r,7bs)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

C17H21NO6 (335.1369)


   

(2s,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

(2s,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C17H21NO6 (335.1369)


   

7-[(2s)-2,3-dihydroxy-3-methylbutyl]-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

7-[(2s)-2,3-dihydroxy-3-methylbutyl]-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

C17H21NO6 (335.1369)


   

(2s)-2-amino-4-{[(1r)-1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-(methylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-(methylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C12H21N3O6S (335.1151)


   

n-{[(2s,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2s,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   

methyl 2-(methylamino)-5-[(3s)-1h,2h,3h,9h-pyrrolo[2,1-b]quinazolin-3-yl]benzoate

methyl 2-(methylamino)-5-[(3s)-1h,2h,3h,9h-pyrrolo[2,1-b]quinazolin-3-yl]benzoate

C20H21N3O2 (335.1634)


   

(2r)-17-oxa-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16(21),18-hexaene-7,15,20-trione

(2r)-17-oxa-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16(21),18-hexaene-7,15,20-trione

C18H13N3O4 (335.0906)


   

2-[6-(1-carboxyethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

2-[6-(1-carboxyethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

C16H17NO7 (335.1005)


   

(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)-2-(3-methylbut-1-en-1-yl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)-2-(3-methylbut-1-en-1-yl)oxolane-3,4-diol

C15H21N5O4 (335.1593)


   

5-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]purin-9-yl}-2-(hydroxymethyl)oxolan-3-ol

5-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]purin-9-yl}-2-(hydroxymethyl)oxolan-3-ol

C15H21N5O4 (335.1593)


   

n-{[(2s,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2s,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   

(2s)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

(2s)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

C17H21NO6 (335.1369)


   

methyl 2-({9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl}amino)benzoate

methyl 2-({9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl}amino)benzoate

C19H17N3O3 (335.127)


   

4-(hydroxymethyl)-6-{[2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}cyclohex-4-ene-1,2,3-triol

4-(hydroxymethyl)-6-{[2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}cyclohex-4-ene-1,2,3-triol

C14H25NO8 (335.158)


   

3-{3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl}-2-methylprop-2-enoic acid

3-{3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl}-2-methylprop-2-enoic acid

C17H21NO6 (335.1369)


   

(3r)-3-[2-(dimethylamino)phenyl]-5-methoxy-1h,2h,3h-pyrrolo[2,1-b]quinazolin-9-one

(3r)-3-[2-(dimethylamino)phenyl]-5-methoxy-1h,2h,3h-pyrrolo[2,1-b]quinazolin-9-one

C20H21N3O2 (335.1634)


   

2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]propanoic acid

2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]propanoic acid

C16H17NO7 (335.1005)


   

1-chloro-n-[(2s,6e)-2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl]methanecarbonimidoyl chloride

1-chloro-n-[(2s,6e)-2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl]methanecarbonimidoyl chloride

C16H24Cl3N (335.0974)


   

(3z,6z)-3-ethylidene-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}pyrazine-2,5-diol

(3z,6z)-3-ethylidene-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}pyrazine-2,5-diol

C20H21N3O2 (335.1634)


   

(3s,4r)-3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

(3s,4r)-3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C17H21NO6 (335.1369)


   

3-(4-hydroxyphenyl)-5-[2-(methylamino)ethyl]-1h,7h-pyrrolo[3,2-f]indole-4,8-dione

3-(4-hydroxyphenyl)-5-[2-(methylamino)ethyl]-1h,7h-pyrrolo[3,2-f]indole-4,8-dione

C19H17N3O3 (335.127)


   

2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

C17H21NO6 (335.1369)


   

(2e,4e,6e,8e)-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-9-(2-methylphenyl)nona-2,4,6,8-tetraenimidic acid

(2e,4e,6e,8e)-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-9-(2-methylphenyl)nona-2,4,6,8-tetraenimidic acid

C21H21NO3 (335.1521)